Panel Discussion: The New Landscape in NDD investing: How the 2021 Events Have Changed Outlooks

Time: 3:00 pm
day: Day 2 afternoon


  • Hearing how new mechanisms and modalities have opened doors for early stage investment
  • Exploring new regulatory approvals, and their effect on the funding environment for clinical stage opportunities
  • Public market reception for neuro focused companies, and the effect on M&A